Drug Shortage Report for CEFAZOLIN FOR INJECTION USP
Report ID | 33327 |
Drug Identification Number | 02308959 |
Brand name | CEFAZOLIN FOR INJECTION USP |
Common or Proper name | CEFAZOLIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CEFAZOLIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-12-12 |
Estimated end date | 2018-05-04 |
Actual end date | 2018-04-30 |
Shortage status | Resolved |
Updated date | 2018-05-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-05-03 | French | Compare |
v9 | 2018-05-03 | English | Compare |
v8 | 2018-04-19 | French | Compare |
v7 | 2018-04-19 | English | Compare |
v6 | 2018-04-13 | French | Compare |
v5 | 2018-04-13 | English | Compare |
v4 | 2018-03-02 | French | Compare |
v3 | 2018-03-02 | English | Compare |
v2 | 2017-12-15 | French | Compare |
v1 | 2017-12-15 | English | Compare |
Showing 1 to 10 of 10